ReShape Lifesciences Inc. Files 8-K Report
Ticker: HIND · Form: 8-K · Filed: May 28, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 8-K |
| Filed Date | May 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, company-information
TL;DR
ReShape Lifesciences filed an 8-K with updated HQ address and confirmed former name Obalon Therapeutics.
AI Summary
On May 28, 2025, ReShape Lifesciences Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 18 Technology Drive, Suite 110, Irvine, CA 92618, with a phone number of (949) 429-6680. The report also lists the company's former name as Obalon Therapeutics Inc., with a date of name change on February 20, 2008.
Why It Matters
This 8-K filing provides updated corporate information, including the company's current address and former name, which is important for investors and stakeholders to maintain accurate records.
Risk Assessment
Risk Level: low — This filing is routine corporate information and does not indicate any significant financial or operational changes.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Registrant
- Obalon Therapeutics Inc. (company) — Former company name
- May 28, 2025 (date) — Date of report
- 18 Technology Drive, Suite 110, Irvine, CA 92618 (address) — Principal executive offices
- February 20, 2008 (date) — Date of name change
FAQ
What is the current principal executive office address for ReShape Lifesciences Inc.?
The current principal executive office address is 18 Technology Drive, Suite 110, Irvine, CA 92618.
What was ReShape Lifesciences Inc.'s former company name?
ReShape Lifesciences Inc.'s former company name was Obalon Therapeutics Inc.
When did the company change its name from Obalon Therapeutics Inc.?
The date of the name change from Obalon Therapeutics Inc. was February 20, 2008.
What is the telephone number for ReShape Lifesciences Inc.?
The telephone number for ReShape Lifesciences Inc. is (949) 429-6680.
What is the filing date of this 8-K report?
The date of the report, which is the earliest event reported, is May 28, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding ReShape Lifesciences Inc. (HIND).